AP NEWS
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Arbutus to Present at Upcoming May 2019 Conferences

May 13, 2019

WARMINSTER, Pa., May 13, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Mark J. Murray, Arbutus’ President and CEO, will present at the following conferences in May 2019:

UBS Global Healthcare Conference Monday, May 20, 2019, 1:00 PM ET – New York RBC Capital Markets Healthcare Conference Tuesday, May 21, 2019, 11:00 AM ET – New York

Live webcasts of the presentations can be accessed through the Investors section of Arbutus’ website at www.arbutusbio.com. A replay of the webcasts will be available for 90 days following the live presentations.

About Arbutus

Arbutus Biopharma Corporation is a publicly-traded (Nasdaq: ABUS) biopharmaceutical company dedicated to discovering, developing, and commercializing a cure for patients suffering from chronic Hepatitis B infection. Arbutus is developing multiple drug candidates, each of which have the potential to improve upon the standard of care and contribute to a curative combination regimen. For more information, visit www.arbutusbio.com.

Contact Information

Investors

Mark MurrayPresident and CEOPhone: 604-419-3200 Email: ir@arbutusbio.com

Pam Murphy Investor Relations ConsultantPhone: 604-419-3200Email: ir@arbutusbio.com